Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FREMANEZUMAB
- Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
- Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis
- COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study
- A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine
- Real World Effectiveness of Eptinezumab in Participants With Migraine
- Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine -
- Fremanezumab, Migraine and Sleep
- Medicinal vs. Orthotic Comparison for Migraine Prevention: A Double-Blind Study
- A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
- A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age
- Efficacy of AJOVY (Fremanezumab-vfrm) on Interictal Migraine Related Burden
- A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
- A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome
- Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
- A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder
- A Study to Test the Effectiveness and Safety of Fremanezumab on Patients With Fibromyalgia
- A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)
- An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
- A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache
- A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)
- A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
- Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine
- Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
- Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine
- A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine
- Assessment of LBR-101 In Chronic Migraine
Clinical trials list
click for details